ISRG
Intuitive Surgical, Inc.
Price Chart
Latest Quote
$376.86
| Previous Close | $372.60 |
| Open | $370.29 |
| Day High | $377.37 |
| Day Low | $365.32 |
| Volume | 1,723,322 |
Stock Information
| Shares Outstanding | 358.28M |
| Cash Equivalents | $5.22B |
| Revenue | $11.03B |
| Net Income | $3.14B |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $135.02B |
| P/E Ratio | 43.22 |
| EPS (TTM) | $8.72 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $128.05B |
| Sales | $11.03B |
| Income | $3.14B |
| Book/sh | $51.34 |
| Cash/sh | $14.56 |
| Employees | 17K |
Financial Ratios
| Quick Ratio | 3.64 |
| Current Ratio | 4.96 |
| EPS Growth TTM | 24.30% |
Returns & Margins
| ROA | 10.51% |
| ROE | 17.42% |
| Gross Margin | 66.68% |
| Operating Margin | 33.60% |
| Profit Margin | 28.45% |
Ownership
| Insider Ownership | 0.51% |
| Institutional Ownership | 89.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 31.22 |
| PEG | 1.80 |
| P/S | 12.24 |
| P/B | 7.34 |
Analyst Data
| Recommendation | buy |
| Target Price | $478.01 |
Technical Indicators
| SMA20 | $382.77 |
| SMA50 | $384.30 |
| SMA200 | $468.59 |
| RSI | 39.03 |
| ATR | 10.7049 |
| Shares Float | 351.21M |
| Short Float | 2.01% |
| Short Ratio | 1.72 |
| Volatility | 1.46 |
| Rel Volume | 0.74 |
Performance History
| Week | -0.51% |
| Month | +6.77% |
| Quarter | -11.25% |
| 6 Months | -25.15% |
| YTD | -32.94% |
| Year | -20.01% |
| 3 Years | +29.78% |
| 5 Years | +8.31% |
| 10 Years | +391.78% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-08-31 | $376.86 | 1,916,829 |
| 2026-08-27 | $367.07 | 1,787,700 |
| 2026-08-26 | $370.42 | 1,664,300 |
| 2026-08-25 | $371.84 | 1,768,000 |
| 2026-08-24 | $373.57 | 1,518,800 |
| 2026-08-21 | $378.81 | 2,010,300 |
| 2026-08-20 | $374.48 | 3,970,900 |
| 2026-08-19 | $397.72 | 2,125,200 |
| 2026-08-18 | $391.18 | 2,385,000 |
| 2026-08-17 | $390.33 | 2,157,800 |
| 2026-08-14 | $394.51 | 1,986,200 |
| 2026-08-13 | $401.27 | 2,355,600 |
| 2026-08-12 | $401.27 | 3,142,600 |
| 2026-08-11 | $401.23 | 4,123,900 |
| 2026-08-10 | $393.38 | 3,221,600 |
| 2026-08-07 | $378.81 | 2,465,700 |
| 2026-08-06 | $373.71 | 2,594,600 |
| 2026-08-05 | $375.20 | 3,286,400 |
| 2026-08-04 | $368.27 | 3,938,800 |
| 2026-08-03 | $375.41 | 3,502,100 |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
đ° Latest News
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
Zacks âĸ 2026-08-28T21:50:01Z
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
Zacks âĸ 2026-08-28T15:30:24Z
Can ISRG Stock Defend Its $131B Valuation?
Trefis âĸ 2026-08-28T00:12:31Z
Is Intuitive Surgical (ISRG) Below Fair Value After Strong Revenue And Procedure Growth?
Simply Wall St. âĸ 2026-08-27T17:08:52Z
3 Healthcare Stocks with Promising Prospects
StockStory âĸ 2026-08-27T15:37:07Z
Intuitive Surgical's Record Cash Flow Gives It an Innovation Advantage
Zacks âĸ 2026-08-27T14:57:00Z
ISRG vs. MDT: Which Surgical Robot Stock Is the Smarter Buy?
Zacks âĸ 2026-08-26T16:54:00Z
Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report?
Zacks âĸ 2026-08-26T15:30:04Z
Eli Lilly Is Pulling Away From the Rest of Healthcare
GuruFocus.com âĸ 2026-08-25T19:30:10ZThe Hospital Bet That Reframes The Intuitive Surgical Stock Story
Trefis âĸ 2026-08-25T15:08:39Z
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,422,400,000 | $2,717,900,000 | $2,394,600,000 | $2,026,200,000 |
| Cost Of Revenue | $3,422,400,000 | $2,717,900,000 | $2,394,600,000 | $2,026,200,000 |
| Total Revenue | $10,064,700,000 | $8,352,100,000 | $7,124,100,000 | $6,222,200,000 |
| Operating Revenue | $10,064,700,000 | $8,352,100,000 | $7,124,100,000 | $6,222,200,000 |
| Expenses | ||||
| Total Expenses | $7,119,200,000 | $6,003,200,000 | $5,357,300,000 | $4,645,100,000 |
| Net Non Operating Interest Income Expense | $365,900,000 | $324,900,000 | $192,100,000 | $29,700,000 |
| Operating Expense | $3,696,800,000 | $3,285,300,000 | $2,962,700,000 | $2,618,900,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,856,000,000 | $2,322,600,000 | $1,798,000,000 | $1,322,300,000 |
| Net Interest Income | $365,900,000 | $324,900,000 | $192,100,000 | $29,700,000 |
| Interest Income | $365,900,000 | $324,900,000 | $192,100,000 | $29,700,000 |
| Normalized Income | $2,856,000,000 | $2,322,600,000 | $1,798,000,000 | $1,322,300,000 |
| Net Income From Continuing And Discontinued Operation | $2,856,000,000 | $2,322,600,000 | $1,798,000,000 | $1,322,300,000 |
| Total Operating Income As Reported | $2,945,500,000 | $2,348,900,000 | $1,766,800,000 | $1,577,100,000 |
| Net Income Common Stockholders | $2,856,000,000 | $2,322,600,000 | $1,798,000,000 | $1,322,300,000 |
| Net Income Including Noncontrolling Interests | $2,876,600,000 | $2,337,500,000 | $1,817,300,000 | $1,344,400,000 |
| Net Income Continuous Operations | $2,876,600,000 | $2,337,500,000 | $1,817,300,000 | $1,344,400,000 |
| Pretax Income | $3,311,400,000 | $2,673,800,000 | $1,958,900,000 | $1,606,800,000 |
| Interest Income Non Operating | $365,900,000 | $324,900,000 | $192,100,000 | $29,700,000 |
| Operating Income | $2,945,500,000 | $2,348,900,000 | $1,766,800,000 | $1,577,100,000 |
| Gross Profit | $6,642,300,000 | $5,634,200,000 | $4,729,500,000 | $4,196,000,000 |
| Per Share | ||||
| Diluted EPS | $7.87 | $6.42 | $5.03 | $3.65 |
| Basic EPS | $8.00 | $6.54 | $5.12 | $3.72 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,622,600,000 | $2,848,600,000 | $2,221,600,000 | $1,942,900,000 |
| Reconciled Depreciation | $677,100,000 | $499,700,000 | $454,800,000 | $365,800,000 |
| EBITDA (Bullshit earnings) | $3,622,600,000 | $2,848,600,000 | $2,221,600,000 | $1,942,900,000 |
| EBIT | $2,945,500,000 | $2,348,900,000 | $1,766,800,000 | $1,577,100,000 |
| Diluted Average Shares | $362,700,000 | $362,000,000 | $357,400,000 | $362,000,000 |
| Basic Average Shares | $356,900,000 | $355,200,000 | $351,200,000 | $355,700,000 |
| Diluted NI Availto Com Stockholders | $2,856,000,000 | $2,322,600,000 | $1,798,000,000 | $1,322,300,000 |
| Minority Interests | $-20,600,000 | $-14,900,000 | $-19,300,000 | $-22,100,000 |
| Tax Provision | $434,800,000 | $336,300,000 | $141,600,000 | $262,400,000 |
| Research And Development | $1,311,800,000 | $1,145,300,000 | $998,800,000 | $879,000,000 |
| Selling General And Administration | $2,385,000,000 | $2,140,000,000 | $1,963,900,000 | $1,739,900,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $17,442,600,000 | $16,063,200,000 | $12,919,800,000 | $10,643,600,000 |
| Total Assets | $20,458,700,000 | $18,743,200,000 | $15,441,500,000 | $12,974,000,000 |
| Total Non Current Assets | $10,679,200,000 | $11,632,200,000 | $7,553,500,000 | $6,721,000,000 |
| Other Non Current Assets | $837,600,000 | $750,900,000 | $597,600,000 | $660,300,000 |
| Non Current Deferred Assets | $1,018,600,000 | $1,045,100,000 | $910,500,000 | $664,600,000 |
| Non Current Deferred Taxes Assets | $1,018,600,000 | $1,045,100,000 | $910,500,000 | $664,600,000 |
| Investmentin Financial Assets | $3,099,200,000 | $4,819,100,000 | $2,120,000,000 | - |
| Goodwill And Other Intangible Assets | $381,400,000 | $370,500,000 | $387,800,000 | $398,300,000 |
| Other Intangible Assets | $11,100,000 | $23,000,000 | $39,100,000 | $49,800,000 |
| Current Assets | $9,779,500,000 | $7,111,000,000 | $7,888,000,000 | $6,253,000,000 |
| Other Current Assets | $376,400,000 | $253,700,000 | $176,700,000 | $168,600,000 |
| Inventory | $1,840,000,000 | $1,487,200,000 | $1,220,600,000 | $893,200,000 |
| Receivables | $1,628,200,000 | $1,356,800,000 | $1,267,500,000 | $1,073,300,000 |
| Other Receivables | $100,900,000 | $131,400,000 | $137,300,000 | $131,200,000 |
| Accounts Receivable | $1,527,300,000 | $1,225,400,000 | $1,130,200,000 | $942,100,000 |
| Allowance For Doubtful Accounts Receivable | $-29,900,000 | $-30,700,000 | $-27,100,000 | $-22,400,000 |
| Gross Accounts Receivable | $1,557,200,000 | $1,256,100,000 | $1,157,300,000 | $964,500,000 |
| Cash Cash Equivalents And Short Term Investments | $5,934,900,000 | $4,013,300,000 | $5,223,200,000 | $4,117,900,000 |
| Cash And Cash Equivalents | $3,368,000,000 | $2,027,400,000 | $2,750,100,000 | $1,581,200,000 |
| Cash Equivalents | $2,853,100,000 | $1,548,000,000 | $2,223,900,000 | $1,084,000,000 |
| Cash Financial | $514,900,000 | $479,400,000 | $526,200,000 | $497,200,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | - | - | - | - |
| Long Term Debt And Capital Lease Obligation | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,517,000,000 | $2,213,600,000 | $2,044,200,000 | $1,861,400,000 |
| Total Non Current Liabilities Net Minority Interest | $510,800,000 | $468,300,000 | $385,500,000 | $439,300,000 |
| Other Non Current Liabilities | $225,800,000 | $175,200,000 | $106,100,000 | $110,300,000 |
| Tradeand Other Payables Non Current | $193,600,000 | $239,000,000 | $233,800,000 | $288,000,000 |
| Non Current Deferred Liabilities | $91,400,000 | $54,100,000 | $45,600,000 | $41,000,000 |
| Current Liabilities | $2,006,200,000 | $1,745,300,000 | $1,658,700,000 | $1,422,100,000 |
| Current Deferred Liabilities | $506,700,000 | $468,800,000 | $446,100,000 | $397,300,000 |
| Payables And Accrued Expenses | $851,100,000 | $740,900,000 | $776,200,000 | $623,200,000 |
| Payables | $380,500,000 | $347,800,000 | $300,100,000 | $243,100,000 |
| Total Tax Payable | $125,400,000 | $154,400,000 | $111,400,000 | $96,100,000 |
| Accounts Payable | $255,100,000 | $193,400,000 | $188,700,000 | $147,000,000 |
| Equity | ||||
| Common Stock Equity | $17,824,000,000 | $16,433,700,000 | $13,307,600,000 | $11,041,900,000 |
| Total Equity Gross Minority Interest | $17,941,700,000 | $16,529,600,000 | $13,397,300,000 | $11,112,600,000 |
| Stockholders Equity | $17,824,000,000 | $16,433,700,000 | $13,307,600,000 | $11,041,900,000 |
| Gains Losses Not Affecting Retained Earnings | $43,300,000 | $-51,300,000 | $-12,200,000 | $-162,500,000 |
| Other Equity Adjustments | $43,300,000 | $-51,300,000 | $-12,200,000 | $-162,500,000 |
| Retained Earnings | $7,011,800,000 | $6,803,300,000 | $4,743,000,000 | $3,500,100,000 |
| Other | ||||
| Ordinary Shares Number | $355,100,000 | $356,600,000 | $352,299,592 | $350,000,000 |
| Share Issued | $355,100,000 | $356,600,000 | $352,299,592 | $350,000,000 |
| Tangible Book Value | $17,442,600,000 | $16,063,200,000 | $12,919,800,000 | $10,643,600,000 |
| Invested Capital | $17,824,000,000 | $16,433,700,000 | $13,307,600,000 | $11,041,900,000 |
| Working Capital | $7,773,300,000 | $5,365,700,000 | $6,229,300,000 | $4,830,900,000 |
| Total Capitalization | $17,824,000,000 | $16,433,700,000 | $13,307,600,000 | $11,041,900,000 |
| Minority Interest | $117,700,000 | $95,900,000 | $89,700,000 | $70,700,000 |
| Additional Paid In Capital | $10,768,500,000 | $9,681,300,000 | $8,576,400,000 | $7,703,900,000 |
| Capital Stock | $400,000 | $400,000 | $400,000 | $400,000 |
| Common Stock | $400,000 | $400,000 | $400,000 | $400,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $91,400,000 | $54,100,000 | $45,600,000 | $41,000,000 |
| Current Deferred Revenue | $506,700,000 | $468,800,000 | $446,100,000 | $397,300,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $648,400,000 | $535,600,000 | $436,400,000 | $401,600,000 |
| Current Accrued Expenses | $470,600,000 | $393,100,000 | $476,100,000 | $380,100,000 |
| Investments And Advances | $3,099,200,000 | $4,819,100,000 | $2,120,000,000 | $2,623,600,000 |
| Available For Sale Securities | $3,099,200,000 | $4,819,100,000 | $2,120,000,000 | - |
| Goodwill | $370,300,000 | $347,500,000 | $348,700,000 | $348,500,000 |
| Net PPE | $5,342,400,000 | $4,646,600,000 | $3,537,600,000 | $2,374,200,000 |
| Accumulated Depreciation | $-2,276,500,000 | $-1,881,300,000 | $-1,562,000,000 | $-1,237,900,000 |
| Gross PPE | $7,618,900,000 | $6,527,900,000 | $5,099,600,000 | $3,612,100,000 |
| Construction In Progress | $638,100,000 | $1,631,600,000 | $1,354,700,000 | $608,600,000 |
| Other Properties | $2,096,600,000 | $1,579,100,000 | $1,149,700,000 | $806,400,000 |
| Machinery Furniture Equipment | $1,570,600,000 | $1,354,500,000 | $1,135,800,000 | $942,000,000 |
| Buildings And Improvements | $2,833,900,000 | $1,486,300,000 | $1,002,100,000 | $866,500,000 |
| Land And Improvements | $479,700,000 | $476,400,000 | $457,300,000 | $388,600,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $991,000,000 | $717,600,000 | $606,000,000 | $350,400,000 |
| Work In Process | $287,900,000 | $205,700,000 | $159,900,000 | $159,900,000 |
| Raw Materials | $561,100,000 | $563,900,000 | $454,700,000 | $382,900,000 |
| Other Short Term Investments | $2,566,900,000 | $1,985,900,000 | $2,473,100,000 | $2,536,700,000 |
| Capital Lease Obligations | - | - | - | - |
| Long Term Capital Lease Obligation | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $2,490,700,000 | $1,303,800,000 | $749,600,000 | $958,400,000 |
| Operating Activities | ||||
| Operating Cash Flow | $3,030,500,000 | $2,415,000,000 | $1,813,800,000 | $1,490,800,000 |
| Cash Flow From Continuing Operating Activities | $3,030,500,000 | $2,415,000,000 | $1,813,800,000 | $1,490,800,000 |
| Operating Gains Losses | $-58,200,000 | $-44,400,000 | $7,300,000 | $45,200,000 |
| Investing Activities | ||||
| Capital Expenditure | $-539,800,000 | $-1,111,200,000 | $-1,064,200,000 | $-532,400,000 |
| Investing Cash Flow | $665,800,000 | $-3,272,800,000 | $-360,100,000 | $1,370,800,000 |
| Cash Flow From Continuing Investing Activities | $665,800,000 | $-3,272,800,000 | $-360,100,000 | $1,370,800,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-2,295,300,000 | $0 | $-416,300,000 | $-2,607,400,000 |
| Financing Cash Flow | $-2,364,100,000 | $150,900,000 | $-287,600,000 | $-2,572,300,000 |
| Cash Flow From Continuing Financing Activities | $-2,364,100,000 | $150,900,000 | $-287,600,000 | $-2,572,300,000 |
| Net Other Financing Charges | $-419,100,000 | $-278,500,000 | $-167,600,000 | $-198,700,000 |
| Net Common Stock Issuance | $-2,295,300,000 | $0 | $-416,300,000 | $-2,607,400,000 |
| Other | ||||
| Income Tax Paid Supplemental Data | $537,900,000 | $466,500,000 | $447,800,000 | $444,200,000 |
| End Cash Position | $3,407,400,000 | $2,062,400,000 | $2,770,100,000 | $1,600,700,000 |
| Beginning Cash Position | $2,062,400,000 | $2,770,100,000 | $1,600,700,000 | $1,306,000,000 |
| Effect Of Exchange Rate Changes | $12,800,000 | $-800,000 | $3,300,000 | $5,400,000 |
| Changes In Cash | $1,332,200,000 | $-706,900,000 | $1,166,100,000 | $289,300,000 |
| Proceeds From Stock Option Exercised | $350,300,000 | $429,400,000 | $296,300,000 | $233,800,000 |
| Common Stock Payments | $-2,295,300,000 | $0 | $-416,300,000 | $-2,607,400,000 |
| Net Investment Purchase And Sale | $1,219,500,000 | $-2,160,600,000 | $713,000,000 | $1,916,000,000 |
| Sale Of Investment | $2,435,400,000 | $2,979,000,000 | $2,920,400,000 | $3,315,500,000 |
| Purchase Of Investment | $-1,215,900,000 | $-5,139,600,000 | $-2,207,400,000 | $-1,399,500,000 |
| Net Business Purchase And Sale | $-13,900,000 | $-1,000,000 | $-8,900,000 | $-12,800,000 |
| Purchase Of Business | $-13,900,000 | $-1,000,000 | $-8,900,000 | $-12,800,000 |
| Net PPE Purchase And Sale | $-539,800,000 | $-1,111,200,000 | $-1,064,200,000 | $-532,400,000 |
| Change In Working Capital | $-1,272,300,000 | $-919,300,000 | $-777,600,000 | $-619,100,000 |
| Change In Other Working Capital | $187,900,000 | $130,500,000 | $88,200,000 | $73,000,000 |
| Change In Other Current Liabilities | $34,100,000 | $108,300,000 | $-32,900,000 | $121,700,000 |
| Change In Payables And Accrued Expense | $57,900,000 | $-400,000 | $41,700,000 | $21,300,000 |
| Change In Payable | $57,900,000 | $-400,000 | $41,700,000 | $21,300,000 |
| Change In Account Payable | $57,900,000 | $-400,000 | $41,700,000 | $21,300,000 |
| Change In Prepaid Assets | $-187,100,000 | $-231,800,000 | $24,200,000 | $-129,200,000 |
| Change In Inventory | $-1,063,400,000 | $-830,000,000 | $-712,500,000 | $-546,600,000 |
| Change In Receivables | $-301,700,000 | $-95,900,000 | $-186,300,000 | $-159,300,000 |
| Changes In Account Receivables | $-301,700,000 | $-95,900,000 | $-186,300,000 | $-159,300,000 |
| Stock Based Compensation | $788,200,000 | $676,800,000 | $592,800,000 | $513,200,000 |
| Deferred Tax | $19,100,000 | $-135,300,000 | $-280,800,000 | $-185,300,000 |
| Deferred Income Tax | $19,100,000 | $-135,300,000 | $-280,800,000 | $-185,300,000 |
| Depreciation Amortization Depletion | $677,100,000 | $499,700,000 | $454,800,000 | $365,800,000 |
| Depreciation And Amortization | $677,100,000 | $499,700,000 | $454,800,000 | $365,800,000 |
| Amortization Cash Flow | $62,400,000 | $54,400,000 | $53,200,000 | $27,800,000 |
| Amortization Of Intangibles | $62,400,000 | $54,400,000 | $53,200,000 | $27,800,000 |
| Depreciation | $614,700,000 | $445,300,000 | $401,600,000 | $338,000,000 |
| Gain Loss On Investment Securities | $-57,200,000 | $-43,300,000 | $7,300,000 | $49,000,000 |
| Gain Loss On Sale Of Business | $-1,000,000 | $-1,100,000 | $0 | $-3,800,000 |
| Net Income From Continuing Operations | $2,876,600,000 | $2,337,500,000 | $1,817,300,000 | $1,344,400,000 |
| Other Non Cash Items | - | $37,700,000 | $33,000,000 | $26,600,000 |
| Purchase Of PPE | - | - | - | - |